Children with Down syndrome (DS, trisomy 21) is at a significantly higher risk of both myeloid and lymphoid leukemia compared to the general pediatric population (1). While considerable strides have been made in treating myeloid leukemia of Down syndrome (MLDS), with a 5-year survival rate now nearing 90%, the outlook for children with Down syndrom
2687 Reached1 Comments
Black Lesion in Old Female
1974 Reached5 Comments11 Likes
Case of Adolescent with Severe Macrocytic Anaemia
53197 Reached503 Comments51 Likes
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1008 Reached2 Comments
Treatment of Recurrent Adult Medulloblastoma
2602 Reached1 Comments4 Likes
Management of Metastatic Prostate Cancer
1039 Reached5 Comments2 Likes